The State of the Psychedelic Industry & Open Questions (Video) Post published:March 3, 2026 Post category:Analysis/News/Pα+
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials Post published:February 27, 2026 Post category:Interviews
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin Use Post published:February 24, 2026 Post category:Psychedelic Bulletin/Pα+
The Psychedelic News Feed: February 16 – 22, 2026 Post published:February 23, 2026 Post category:Psychedelic News Feed Archive
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data Post published:February 20, 2026 Post category:Analysis/News/Pα+
Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts Post published:February 19, 2026 Post category:Analysis
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast Post published:February 17, 2026 Post category:Analysis/News/Pα+
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions Post published:February 17, 2026 Post category:Analysis/News/Pα+
Q4’25 Psychedelic Lobbying Update Post published:February 13, 2026 Post category:Analysis/News/Pα+